Cancer Immunotherapy Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Dec 2019| FMR570A| Fact Market Research

Report Highlights

Cancer Immunotherapy Market - Scope of the Study

This report provides forecasts and analysis of the cancer immunotherapy market. This exclusive study also offers analytical data for the historical period (2016-2019) along with forecasts from 2020 to 2025 in terms of revenue (US$ Mn). The report on the global cancer immunotherapy market includes macroeconomic as well as microeconomic growth indicators. The study provides information on the key drivers and restraints influencing the growth of the cancer immunotherapy market, and their impact on each region during the forecast period. The report also comprises a study of the current challenges impeding the adoption rate and opportunities for manufacturers in the cancer immunotherapy market. This comprehensive study also includes value chain analysis, with a list of vendors and industry stakeholders at each node in the value chain, pipeline snapshot, and cancer epidemiology in every region.

In order to provide stakeholders with a comprehensive view of the cancer immunotherapy market, authors of the report have included detailed competitive analysis and key players with unique selling propositions. The dashboard provides a detailed comparison of manufacturers operating in the cancer immunotherapy market, on parameters such as collective market share and geographic concentration. This detailed study on the cancer immunotherapy market offers incisive insights regarding significant dynamics influencing the movement of the cancer immunotherapy landscape during the forecast period.

Authors of the cancer immunotherapy market report have taken ample care to track the latest market movements to ensure that only accurate information reaches to stakeholders. The study helps these stakeholders in gaining an edge over their competitors. This exclusive guide also tracks the current as well as future trends that are likely to influence the growth of the cancer immunotherapy market during the forecast period. To add to that, the analysis also discusses the threat of substitutes and new entrants, which provides a brief idea regarding the future growth course of the cancer immunotherapy market.

The report provides a detailed competitive dashboard and company profiles of key participants operating in the global market. Some of the key players in the global cancer immunotherapy market include Amgen, Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, Eli Lilly and Company, GlaxoSmithKline Plc., F.Hoffmann-La Roche Ltd., Janssen Biotech, Inc., Novartis AG, Merck & Co., Inc., Pfizer, Inc., Spectrum Pharmaceuticals, Inc., Sanofi, and Takeda Pharmaceuticals.

Cancer Immunotherapy Market - Research Methodology

A number of primary and secondary sources were consulted during the course of the study on the cancer immunotherapy market. Secondary sources include NCBI, cancerresearch.org, WHO, FDA, Google Books, articles, company annual reports, websites, press releases, and publications.

The top-down approach has been used to estimate the cancer immunotherapy market by region. Market numbers for global therapy and therapeutic area segments have been derived using the bottom-up approach, which is cumulative of each region’s demand. Company-level market share has been derived on the basis of revenues reported by key players in the cancer immunotherapy market space. The cancer immunotherapy market has been forecast based on current currency rates.

Request research methodology of this report.

  • Table 1 : Global Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type, 2020–2025
  • Table 2 : Global Cancer Immunotherapy Market Size (US$ Mn) Forecast, By Therapy Type (Immune Checkpoint Inhibitors), 2020–2025
  • Table 3 : Global Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2025
  • Table 4 : Global Cancer Immunotherapy Market Size (US$ Mn) Forecast, by End-User, 2020–2025
  • Table 5 : Global Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Region, 2020–2025
  • Table 6 : North America Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type, 2020–2025
  • Table 7 : North America Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type (Immune Checkpoint Inhibitors), 2020–2025
  • Table 8 : North America Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2025
  • Table 9 : North America Cancer Immunotherapy Market Size (US$ Mn) Forecast, by End-User, 2020–2025
  • Table 10 : North America Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2020–2025
  • Table 11 : Europe Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type, 2020–2025
  • Table 12 : Europe Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type (Immune Checkpoint Inhibitors), 2020–2025
  • Table 13 : Europe Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2025
  • Table 14 : Europe Cancer Immunotherapy Market Size (US$ Mn) Forecast, by End-User, 2020–2025
  • Table 15 : Europe Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2020–2025
  • Table 16 : Europe Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2020–2025
  • Table 17 : Asia Pacific Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type, 2020–2025
  • Table 18 : Asia Pacific Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type (Immune Checkpoint Inhibitors), 2020–2025
  • Table 19 : Asia Pacific Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2025
  • Table 20 : Asia Pacific Cancer Immunotherapy Market Size (US$ Mn) Forecast, by End-User, 2020–2025
  • Table 21 : Asia Pacific Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2020–2025
  • Table 22 : Latin America Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type, 2020–2025
  • Table 23 : Latin America Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type (Immune Checkpoint Inhibitors), 2020–2025
  • Table 24 : Latin America Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapeutic Area, 2020–2025
  • Table 25 : Latin America Cancer Immunotherapy Market Size (US$ Mn) Forecast, by End-User, 2020–2025
  • Table 26 : Latin America Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2020–2025
  • Table 27 : Middle East & Africa Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type, 2020–2025
  • Table 28 : Middle East & Africa Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Therapy Type (Immune Checkpoint Inhibitors), 2020–2025
  • Table 29 : Middle East & Africa Cancer Immunotherapy Market Size (US$ Mn) Forecast, by End-User, 2020–2025
  • Table 30 : Middle East & Africa Cancer Immunotherapy Market Size (US$ Mn) Forecast, by Country, 2020–2025
  • Figure 1 : Global Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 2 : Global Cancer Immunotherapy Market Value Share Analysis, by Therapy Type, 2020 and 2025
  • Figure 3 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Monoclonal Antibodies, 2020–2025
  • Figure 4 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Immune Checkpoint Inhibitors, 2020–2025
  • Figure 5 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Immune System Modulators, 2020–2025
  • Figure 6 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Cancer Vaccines, 2020–2025
  • Figure 7 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Others, 2020–2025
  • Figure 8 : Global Cancer Immunotherapy Market Attractiveness Analysis, by Therapy Type
  • Figure 9 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By PD-1/PD-L1 Type, 2020–2025
  • Figure 10 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By CTLA-4 Type, 2020–2025
  • Figure 11 : Global Cancer Immunotherapy Market Attractiveness Analysis, by Therapy Type (Immune Checkpoint Inhibitors)
  • Figure 12 : Global Cancer Immunotherapy Market Value Share Analysis, by Therapeutic Area, 2020 and 2025
  • Figure 13 : Global Cancer Immunotherapy Market Attractiveness Analysis, by Therapeutic Area
  • Figure 14 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Lung Cancer, 2020–2025
  • Figure 15 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Colorectal Cancer, 2020–2025
  • Figure 16 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Breast Cancer, 2020–2025
  • Figure 17 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Prostate Cancer, 2020–2025
  • Figure 18 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Melanoma, 2020–2025
  • Figure 19 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Blood Cancers, 2020–2025
  • Figure 20 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Other Cancers, 2020–2025
  • Figure 21 : Global Cancer Immunotherapy Market Value Share Analysis, by End-User, 2020 and 2025
  • Figure 22 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Hospitals, 2020–2025
  • Figure 23 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By ASC’s, 2020–2025
  • Figure 24 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Cancer Research Institutes, 2020–2025
  • Figure 25 : Global Cancer Immunotherapy Market Revenue (US$ Mn) and Y-o-Y growth (%), By Clinics, 2020–2025
  • Figure 26 : Global Cancer Immunotherapy Market Attractiveness Analysis, by End-User
  • Figure 27 : Global Cancer Immunotherapy Market Value Share Analysis, by Region, 2020 and 2025
  • Figure 28 : Global Cancer Immunotherapy Market Attractiveness Analysis, by Region
  • Figure 29 : North America Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 30 : North America Cancer Immunotherapy Market Attractiveness Analysis By Country
  • Figure 31 : North America Market Value Share Analysis, by Therapy Type, 2020 and 2025
  • Figure 32 : North America Market Value Share Analysis, by Therapeutic Area, 2020 and 2025
  • Figure 33 : North America Market Value Share Analysis, by End-User, 2020 and 2025
  • Figure 34 : North America Market Value Share Analysis, by Country, 2020 and 2025
  • Figure 35 : U.S. Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 36 : U.S. Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 37 : Canada Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 38 : Canada Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 39 : North America Cancer Immunotherapy Market Attractiveness by Therapy Type
  • Figure 40 : North America Cancer Immunotherapy Market Attractiveness by Therapeutic Area
  • Figure 41 : North America Cancer Immunotherapy Market Attractiveness by End-User
  • Figure 42 : Europe Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 43 : Europe Cancer Immunotherapy Market Attractiveness Analysis by Country
  • Figure 44 : Europe Cancer Immunotherapy Market Value Share Analysis, by Therapy Type, 2020 and 2025
  • Figure 45 : Europe Cancer Immunotherapy Market Value Share Analysis, by Therapeutic Area, 2020 and 2025
  • Figure 46 : Europe Cancer Immunotherapy Market Value Share Analysis, by End-User, 2020 and 2025
  • Figure 47 : Europe Cancer Immunotherapy Market Value Share Analysis, by Country, 2020 and 2025
  • Figure 48 : Germany Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 49 : Germany Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 50 : U.K. Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 51 : U.K. Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 52 : France Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 53 : France Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 54 : Spain Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 55 : Spain Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 56 : Italy Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 57 : Italy Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 58 : Rest of Europe Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 59 : Rest of Europe Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 60 : Europe Cancer Immunotherapy Market Attractiveness by Therapy Type
  • Figure 61 : Europe Cancer Immunotherapy Market Attractiveness by Therapeutic Area
  • Figure 62 : Europe Cancer Immunotherapy Market Attractiveness by End-User
  • Figure 63 : Asia Pacific Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 64 : Asia Pacific Cancer Immunotherapy Market Attractiveness Analysis, By Country
  • Figure 65 : Asia Pacific Cancer Immunotherapy Market Value Share Analysis, by Therapy Type, 2020 and 2025
  • Figure 66 : Asia Pacific Cancer Immunotherapy Market Value Share Analysis, by Therapy Type, 2020 and 2025
  • Figure 67 : Asia Pacific Cancer Immunotherapy Market Value Share Analysis, by End-User, 2020 and 2025
  • Figure 68 : Asia Pacific Cancer Immunotherapy Market Value Share Analysis, by Country, 2020 and 2025
  • Figure 69 : Japan Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 70 : Japan Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 71 : China Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 72 : China Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 73 : India Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 74 : India Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 75 : Australia Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 76 : Australia Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 77 : New Zealand Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 78 : New Zealand Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 79 : Rest of Asia Pacific Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 80 : Rest of Asia Pacific Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 81 : Asia Pacific Cancer Immunotherapy Market Attractiveness by Therapy Type
  • Figure 82 : Asia Pacific Cancer Immunotherapy Market Attractiveness by Therapeutic Area
  • Figure 83 : Asia Pacific Cancer Immunotherapy Market Attractiveness by End-User
  • Figure 84 : Asia Pacific Cancer Immunotherapy Market Attractiveness by End-User
  • Figure 85 : Latin America Cancer Immunotherapy Market Attractiveness Analysis by Country
  • Figure 86 : Latin America Cancer Immunotherapy Market Value Share Analysis, by Therapy Type, 2020 and 2025
  • Figure 87 : Latin America Cancer Immunotherapy Market Value Share Analysis, by Therapeutic Area, 2020 and 2025
  • Figure 88 : Latin America Cancer Immunotherapy Market Value Share Analysis, by End-User, 2020 and 2025
  • Figure 89 : Latin America Cancer Immunotherapy Market Value Share Analysis, by Country, 2020 and 2025
  • Figure 90 : Brazil Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 91 : Brazil Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 92 : Mexico Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 93 : Mexico Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 94 : Mexico Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 95 : Rest of Latin America Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 96 : Latin America Cancer Immunotherapy Market Attractiveness by Therapy Type
  • Figure 97 : Latin America Cancer Immunotherapy Market Attractiveness by Therapeutic Area
  • Figure 98 : Latin America Cancer Immunotherapy Market Attractiveness by End-User
  • Figure 99 : Middle East & Africa Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 100 : Middle East & Africa Cancer Immunotherapy Market Attractiveness Analysis by Country
  • Figure 101 : Middle East & Africa Cancer Immunotherapy Market Value Share Analysis, by Therapy Type, 2020 and 2025
  • Figure 102 : Middle East & Africa Cancer Immunotherapy Market Value Share Analysis, by Therapeutic Area, 2020 and 2025
  • Figure 103 : Middle East & Africa Cancer Immunotherapy Market Value Share Analysis, by End-User, 2020 and 2025
  • Figure 104 : Middle East & Africa Cancer Immunotherapy Market Value Share Analysis, by End-User, 2020 and 2025
  • Figure 105 : Saudi Arabia Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 106 : Saudi Arabia Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 107 : UAE Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 108 : UAE Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 109 : RSA Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 110 : RSA Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 111 : Rest of Middle East & Africa Cancer Immunotherapy Market Size (US$ Mn) Forecast, 2020–2025
  • Figure 112 : Rest of Middle East & Africa Cancer Immunotherapy Market Absolute $ Opportunity (US$ Mn), 2020–2025
  • Figure 113 : Middle East & Africa Cancer Immunotherapy Market Attractiveness by Therapy Type
  • Figure 114 : Middle East & Africa Cancer Immunotherapy Market Attractiveness by Therapeutic Area
  • Figure 115 : Middle East & Africa Cancer Immunotherapy Market Attractiveness by End-User

Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report